Herpes outbreaks happen when a virus that has been sitting dormant in nerve cells wakes up, travels back along nerve fibers to the skin, and starts replicating. The virus never fully leaves the body after the initial infection, so flare-ups are a recurring possibility throughout a person’s life. What actually pulls the virus out of dormancy varies from person to person, but the most commonly reported triggers include psychological stress, illness with fever, physical trauma to the affected area, hormonal shifts, fatigue, and anything that suppresses the immune system. The interplay between these triggers and each person’s biology explains why some people get outbreaks monthly while others go years without one.
How the Virus Stays Hidden Between Outbreaks
After a first infection, herpes simplex virus particles travel from the skin’s surface into nearby sensory nerve endings. From there, the virus hitches a ride along the nerve fiber to the nerve cell body, which sits in a cluster of neurons called a ganglion. For oral herpes, that cluster is in the trigeminal ganglion near the base of the skull. For genital herpes, it is in the sacral ganglia near the lower spine. Once inside, the viral DNA settles into the nerve cell’s nucleus and essentially goes quiet, producing almost none of its usual proteins. This dormant state can persist for the rest of a person’s life.
1Cell Host & Microbe. Viruses and the Nervous SystemPart of what keeps the virus asleep is an active patrol by immune cells. Specialized memory T cells take up long-term residence right inside the ganglia, constantly surveilling latently infected neurons. These cells can detect early signs of viral gene activity and shut it down before it leads to full reactivation.
2PubMed Central. Immunological control of herpes simplex virus infectionsReactivation happens when something disrupts this balance. The triggers activate different cellular processes that push the viral DNA from its silent state back into active gene expression. Within about one to two days of that molecular switch flipping, the virus can produce large numbers of new copies and begin traveling back down the nerve to the skin surface.
3Virology. Strength in diversity: Understanding the pathways to herpes simplex virus reactivation The cellular factors that initiate this process are still not fully mapped, though researchers have identified that certain viral proteins, previously thought to appear only late in the replication cycle, can act as molecular triggers following stresses like elevated body temperature.4FEMS Microbiology Reviews. The molecular basis of herpes simplex virus latency
Psychological Stress
Stress is the trigger people ask about most, and the research supports the connection, though with some nuance. In a well-known animal study, disrupting the social hierarchy within mouse colonies increased aggression and activated the body’s main stress-hormone system. This social stress reactivated latent herpes in over 40% of the infected animals. Interestingly, physical restraint stress, which also activated stress hormones, did not cause reactivation, suggesting the type of stress matters, not just its intensity.
5PubMed Central. Social stress and the reactivation of latent herpes simplex virus type 1In humans, the picture is a bit messier. A study of women with genital HSV-2 tracked daily psychological distress alongside viral shedding and found that distress measured about five days before a shedding episode predicted the event. That roughly five-day window matches the estimated travel time for the virus from the sacral ganglia to the genital skin, which suggests the stress acts at the site of latency itself rather than just weakening immune defenses at the skin surface.
6PubMed Central. The Effects of Daily Distress and Personality on Genital HSV Shedding and Lesions in a Randomized, Double-blind, Placebo-Controlled, Crossover Trial of Acyclovir in HSV-2 Seropositive WomenThat said, not every stressful day brings an outbreak. The relationship between stress and reactivation is probabilistic, not automatic. Many people go through intensely stressful periods without a single lesion. Still, sustained or repeated psychological distress is one of the more reliably documented triggers in the literature.
Sleep Deprivation and Physical Fatigue
Fatigue and sleep loss overlap with stress but deserve their own mention because they appear to have an independent effect. A study of medical residents compared herpes virus reactivation during rest periods versus working shifts under low- and high-stress conditions. HSV DNA levels actually decreased under low stress but increased under high stress, and overall reactivation across herpes viruses was significantly higher during both low- and high-stress work shifts compared to rest periods.
7PubMed Central. Fatigue in Medical Residents Leads to Reactivation of Herpes Virus LatencyThe practical takeaway is straightforward: chronic sleep debt and physical exhaustion can lower the immune threshold enough to let the virus slip past the T cells guarding the ganglia. If you notice outbreaks clustering around periods of overwork or poor sleep, you are not imagining the pattern.
Physical Trauma to the Affected Area
Direct physical injury to skin in or near the area where the virus resides can provoke an outbreak. This is well recognized in clinical settings, particularly around cosmetic procedures. Dermal filler injections in the face, for instance, have been documented to trigger herpes reactivation through at least three proposed mechanisms: direct damage to nerve fibers by the needle, local inflammation from the filler material, and the body’s general stress response to the procedure. In reported cases, the outbreak typically appears in the area where the filler was injected, often within 24 to 48 hours.
8PubMed Central. Herpes reactivation after the injection of hyaluronic acid dermal filler: A case report and review of literatureThe risk extends to other cosmetic interventions as well. While reactivation of oral herpes following cosmetic procedures is considered rare, the risk is acknowledged broadly enough that clinicians are advised to screen for a history of cold sores before certain facial treatments.
9PubMed Central. Guideline for the Management Herpes Simplex 1 and Cosmetic Interventions Dental work, facial surgery, and even aggressive sunburn on the lips can trigger oral outbreaks through similar local-trauma pathways. For genital herpes, friction from sexual activity is a commonly reported physical trigger, though the line between trauma-induced reactivation and simple irritation of existing subclinical shedding is not always clear.
Hormonal Shifts
Many women report that genital herpes outbreaks cluster around menstruation, and there is some data to support the connection. A study following women who were not using hormonal contraception found that HSV-2 was detectable on about 21% of days during the follicular phase (the first half of the cycle, starting with menstruation) compared to about 18% of days in the luteal phase. Genital lesions showed a similar trend, though that difference did not reach statistical significance.
10PubMed Central. The effect of hormonal contraception and menstrual cycle timing on genital herpes simplex virus-2 shedding and lesionsThe difference is modest, which matches the clinical experience that menstruation is a trigger for some women but by no means all. The mechanism likely involves hormonal fluctuations affecting local mucosal immunity. Estrogen and progesterone influence immune cell activity in the genital tract, and the drop in both hormones right before and during menstruation may create a brief window of reduced local defense.
Immunosuppression
Anything that meaningfully weakens the immune system raises the risk of herpes reactivation. This includes medical immunosuppression (organ transplant recipients on anti-rejection drugs, people undergoing chemotherapy), HIV infection, and high-dose corticosteroid therapy. The connection is strong enough that organ transplant recipients and cancer patients undergoing intensive treatment are routinely screened for herpes antibodies, and those who test positive are given preventive antiviral medication during the period of greatest immune suppression.
11PubMed Central. Acyclovir prophylaxis for herpes simplex virus infectionImmune suppression from these factors plays a central role in herpes reactivation and often requires a comprehensive management approach rather than treating outbreaks one at a time.
12PubMed Central. Identifying the Multifactorial Triggers of Monthly Recurrent HSV-1 Reactivation: A Case Report For people with healthy immune systems, everyday mild immune dips from a cold, poor nutrition, or a bad week of sleep can tip the balance just enough for reactivation. The effect is subtler than in profoundly immunosuppressed patients, but the mechanism is the same: when the immune cells patrolling the ganglia are less effective, the virus has a better chance of waking up.
Why HSV-2 Recurs More Often Than HSV-1 in the Genitals
Not all herpes outbreaks are created equal. HSV-2 causes genital recurrences far more frequently than HSV-1 does when HSV-1 infects the same site. Research in animal models has shown that after infection with equivalent amounts of virus, HSV-2 establishes a larger reservoir of latent viral DNA in the relevant ganglia than HSV-1 does. Those infections then recur more often and the episodes last longer.
13PubMed Central. The quantity of latent viral DNA correlates with the relative rates at which herpes simplex virus types 1 and 2 cause recurrent genital herpes outbreaksThis has real practical implications. If you have been diagnosed with genital herpes, the type matters for predicting your outbreak frequency. Someone with genital HSV-1 may have one or two recurrences in the first year and then very few after that. Someone with genital HSV-2 may have four to six recurrences in the first year, sometimes more, with the frequency gradually declining over years. The triggers described throughout this article apply to both types, but HSV-2 seems to have a lower threshold for reactivation in the genital area because it maintains a larger latent footprint.
Subclinical Shedding and What It Means for Outbreaks
Most people think of herpes reactivation as synonymous with visible sores, but the virus reactivates without causing noticeable symptoms far more often than it causes lesions. In a large study of people with genital HSV-2, the virus was detectable on about 20% of days among those who experienced symptomatic outbreaks and about 10% of days among those who had never noticed symptoms. On the majority of those shedding days, no lesion was present.
14PubMed Central. Genital Shedding of Herpes Simplex Virus Among Symptomatic and Asymptomatic Persons with HSV-2 InfectionThis means the same triggers that cause visible outbreaks are also pushing the virus to reactivate in smaller, invisible episodes far more often. It also means that the absence of outbreaks does not mean the virus is inactive. The same study found that the amount of virus shed during these subclinical episodes was similar regardless of whether the person was a “symptomatic” or “asymptomatic” carrier. This has obvious implications for transmission and helps explain why herpes spreads so efficiently in the population.
The Lysine and Arginine Question
One of the longest-running dietary ideas about herpes management involves the amino acids lysine and arginine. In laboratory studies, arginine deficiency suppressed herpes virus replication in cell cultures, and lysine, which competes with arginine, antagonized the virus’s ability to use arginine for growth.
15PubMed. Relation of arginine-lysine antagonism to herpes simplex growth in tissue culture The proposed mechanism is that lysine interferes with the formation of viral proteins by competing with arginine, which the virus needs for replication.
16PubMed. L-lysine: Its antagonism with L-arginine in controlling viral infectionThe reality in actual human use is less impressive. A review of the clinical evidence found that lysine supplementation at doses below one gram per day, without also restricting dietary arginine, appeared ineffective for preventing outbreaks. Doses above three grams per day seemed to improve how patients felt about their symptoms, but the overall evidence for prevention remains weak.
17PubMed Central. Lysine for Herpes Simplex Prophylaxis: A Review of the Evidence In short, the biochemistry is real, but translating it into a practical dietary strategy has not panned out convincingly. If you want to try lysine, the evidence suggests you would need a high dose combined with limiting arginine-rich foods like nuts and chocolate, and even then, the benefit is modest at best compared to antiviral medication.
Your Genes Affect How Often You Get Outbreaks
People infected with the same strain of herpes can have wildly different clinical courses, and genetics is one reason why. Nearly all adults have been exposed to HSV-1 at some point, yet only some develop recurrent cold sores. Researchers have identified a gene region informally called “cold sore susceptibility gene-1” where certain genetic variants were linked to more frequent and more severe cold sore episodes, while other variants appeared to be protective.
18Human Genome Variation. Cold sore susceptibility gene-1 genotypes affect the expression of herpes labialis in unrelated human subjectsBeyond that specific gene, a broader study examined multiple immune-system gene families and found that the risk of developing clinical HSV-1 disease was influenced by variations in genes involved in both the innate and adaptive immune response, particularly those governing cytotoxic immune cells. No single gene dominates, but collectively these variations help explain why one person gets cold sores every month and their sibling, infected with the same virus, gets one every few years.
19The Journal of Immunology. Host Genetic Factors in Susceptibility to Herpes Simplex Type 1 Virus Infection: Contribution of Polymorphic Genes at the Interface of Innate and Adaptive ImmunityAntiviral Suppression
For people who get frequent outbreaks, daily antiviral medication is the most effective way to reduce them. In a placebo-controlled trial, once-daily valacyclovir prevented or delayed 85% of the recurrences that would have occurred with placebo. After about four months of treatment, roughly 69% of those on the medication remained outbreak-free compared to under 10% on placebo.
20PubMed. Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapyThe effective dose depends on how often you get outbreaks. Research has shown that people with fewer than ten recurrences per year tend to do well on a lower daily dose, while those with ten or more per year benefit from a higher dose or twice-daily dosing. Acyclovir taken twice daily showed similar effectiveness to the higher valacyclovir regimens.
21PubMed. Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study Daily suppressive therapy also reduces subclinical shedding, which lowers the chance of passing the virus to a partner.
The Gut Microbiome Connection
An emerging and somewhat surprising area of research links gut bacteria to herpes outcomes. In animal studies, mice treated with antibiotics to deplete their gut bacteria showed higher HSV-1 replication and more severe symptoms when infected, suggesting that commensal gut bacteria contribute to systemic resistance to viral infection even in organs far from the gut.
22Immunity. The gut microbiota drive systemic antiviral immunity via cGAS-STING and DNA-containing membrane vesiclesOther research has found that HSV-1 infection in the nervous system itself can disrupt the gut microbiome, and that a metabolite produced by certain gut bacteria, particularly species of Lactobacillus, can activate a cellular cleanup process in immune cells of the brain that helps suppress herpes-related inflammation.
23PubMed Central. The intestinal microbial metabolite nicotinamide n-oxide prevents herpes simplex encephalitis via activating mitophagy in microglia This is early-stage science, mostly in mice, and it would be premature to claim that taking a probiotic will reduce your herpes outbreaks. But the finding that the gut and the nervous system talk to each other in ways that affect herpes latency is a genuine and active area of investigation.
Gene Editing as a Potential Cure
Current antivirals manage outbreaks but do not touch the latent virus sitting in the ganglia. The most ambitious frontier in herpes research is using gene-editing tools to go after that reservoir directly. One approach uses specially engineered enzymes called meganucleases, delivered into nerve cells by viral vectors, to cut the latent herpes DNA. In mouse models of facial and genital infection, this strategy eliminated 90% or more of latent HSV-1 DNA, and up to 97% in some genital infection models.
24Nature Communications. Gene editing for latent herpes simplex virus infection reduces viral load and shedding in vivoA separate team has used CRISPR-based tools packaged into particles that can travel from the eye’s surface back along nerve fibers to the trigeminal ganglia, eliminating the viral reservoir in mouse models of eye herpes and blocking disease recurrence.
25Nature Biotechnology. Targeting herpes simplex virus with CRISPR–Cas9 cures herpetic stromal keratitis in mice Neither approach is anywhere near ready for human use, and the challenges of safely delivering gene-editing tools to scattered neurons deep inside a person’s nervous system are formidable. But the fact that researchers can now erase most of the latent DNA in animal models represents a genuine shift from managing symptoms to potentially curing the underlying infection. Human trials for at least one meganuclease-based approach are being planned, and the field is moving faster than most people realize.
An Extremely Old Relationship
One reason herpes is so difficult to eliminate is that the virus has been co-evolving with its hosts for an extraordinarily long time. Herpes simplex viruses have been diversifying alongside primates for millions of years, with the relationship traceable at least as far back as the common ancestor of New World monkeys, Old World monkeys, and apes.
26PubMed Central. Evolutionary origins of human herpes simplex viruses 1 and 2 HSV-2 in particular appears to have ancient origins as a cross-species jump, when an ape simplex virus infected early human ancestors in Africa.
27Nature Communications. Phylogeographic analysis reveals an ancient East African origin of human herpes simplex virus 2 dispersal out-of-AfricaThis deep evolutionary history explains why the virus is so exquisitely adapted to human neurons. Its latency strategy, its ability to evade immune detection for decades, and its sensitivity to the precise stress signals of its host are not accidental features. They are the product of millions of years of natural selection. It also explains why building an effective vaccine has been so difficult: the virus has had ample time to evolve countermeasures against virtually every arm of the human immune response.